当前位置: 首页 > 期刊 > 《现代医药卫生》 > 2007年第23期
编号:11512514
评价多个肿瘤标志物在非小细胞肺癌临床中的应用价值(3)
http://www.100md.com 2007年12月1日 《现代医药卫生》 2007年第23期
     [7] Nakashima T,Huang CL,Liu D,et al.Expression of Vascular endothe-lial growth factor-A and Vascular endothelial growth factor-C as pro-gnostic factors for non-smallcell Lung Cancer[J].Med Sci Monit,2004,10:157.

    [8] Sodek J,Ganss B,Mckee MD.Ostenpontin [J].crit REV Oral Biol.Med,2000,11(3):279.

    [9] Adwan H,Bauerle TJ.Colning and sequence analysis of rat bone sialo protein (osteopontin ) cDNA reveals an Arg-Gly-Aspcell-binding sequence [J].Proc Natl Acard Sci USA,1996,83(23):8819.

    [10] LE Q T,Raychaudhuri S.Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas [J].Clin Cancer Res,2004,9(1):56.

    [11] Hotte SJ,Winquist E,Stitte L,et al. Plasma osteopontin: association with survival and metastasis to bone in men with hormone-refracto-ry prostate carcinoma[J].Cancer,2002,95(3):506.

    [12] Weber GF.The metastasis gene.osteopontin:a candidate target for can-cer therapy[J].Biochim Biophys Acta,2003,1552(2): 61.

    收稿日期:2007-07-24, http://www.100md.com(胡春霞 张 锦)
上一页1 2 3